Read + Share
Amedeo Smart
Independent Medical Education
Bauersachs RM, Szarek M, Brodmann M, Gudz I, et al. Total Ischemic Event Reduction with Rivaroxaban after Peripheral Arterial Revascularization in the VOYAGER PAD Trial. J Am Coll Cardiol 2021 May 7. pii: S0735-1097(21)05016.PMID: 34010631
Email
LinkedIn
Facebook
Twitter
Privacy Policy